Matthew Cohen's most recent trade in Arrowhead Pharmaceuticals Inc. was a trade of 11,882 Common Stock done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arrowhead Pharma Inc | Matthew Gregory Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 11,882 | 11,882 (0%) | 0% | 0 | Common Stock | |
| ZeroStack Corp | Matthew Cohen | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.24 per share. | 18 May 2023 | 90,146 | 329,610 | - | 0.2 | 21,635 | Common Shares |